FDA Center for Drug Evaluation & Research Issues Warning Letter to NuScience Peptides
September 02, 2026
September 02, 2026
WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to NuScience Peptides LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Joseph and Ratsamy DeRosa, Managers, NuScience Peptides LLC, 20311 Chartwell Center Dr., Suite 212, Cornelius, NC 28031, United States, info@nusciencepeptides.com
Issuing Office: Center for Drug Evaluation and Research (CDER), Unit . . .
* * *
Recipient: Joseph and Ratsamy DeRosa, Managers, NuScience Peptides LLC, 20311 Chartwell Center Dr., Suite 212, Cornelius, NC 28031, United States, info@nusciencepeptides.com
Issuing Office: Center for Drug Evaluation and Research (CDER), Unit . . .
